RADIATION THERAPY ONCOLOGY GROUP
RTOG 0621
ADJUVANT 3DCRT/IMRT IN COMBINATION WITH ANDROGEN SUPPRESSION AND DOCETAXEL FOR HIGH RISK PROSTATE CANCER PATIENTS POST-PROSTATECTOMY: A PHASE II TRIAL
RTOG 0621
ADJUVANT 3DCRT/IMRT IN COMBINATION WITH ANDROGEN SUPPRESSION AND DOCETAXEL FOR HIGH RISK PROSTATE CANCER PATIENTS POST-PROSTATECTOMY: A PHASE II TRIAL
Protocol Participation Information
- Credentialing
- Credentialing Requirements
- Dry Run Guidelines (Please contact Bill Straube at (314) 362-9762)
- Facility Questionnaire: Part I is required for this protocol.
-
RPC Phantom Dosimetry Test (Prostate Phantom)
- Fill out the RPC Phantom Request Form to request shipment of a phantom.
- Phantom irradiation guidelines and forms (Contact the RPC at 713-745-8989 with any questions.)
- Contact Bill Straube at (314) 362-9762 regarding submission of phantom treatment planning data to the ITC.
- ITC Digital Data Submission Test
- Contact Bill Straube at (314) 362-9762 for instructions.
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- Data Submission Checklist
- ATC Compliant Treatment Planning Systems
- Structure Names
- Contouring Examples (for organs-at-risk)
- Protocol Text (http://www.rtog.org/)
Back to protocols
